A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

Volume 327:581-587		August 27, 1992		Number 9

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

JO Kahn, SW Lagakos, DD Richman, A Cross, C Pettinelli, SH Liou, M Brown, PA Volberding, CS Crumpacker, G Beall, and et al.

Abstract

Add to Personal Archive

Add to Citation Manager

E-mail When Cited

PubMed Citation

San Francisco General Hospital, Calif. 94110.

This article has been cited by other articles:

Cooper, D. A. (2002). Update on Didanosine. J Int Assoc Physicians AIDS Care (Chic Ill) 1: 15-25 [Abstract]
Schwarcz, S. K., Hsu, L. C., Vittinghoff, E., Katz, M. H. (2000). Impact of Protease Inhibitors and Other Antiretroviral Treatments on Acquired Immunodeficiency Syndrome Survival in San Francisco, California, 1987-1996. Am J Epidemiol 152: 178-185 [Abstract] [Full Text]
Patick, A. K., Potts, K. E. (1998). Protease Inhibitors as Antiviral Agents. Clin. Microbiol. Rev. 11: 614-627 [Abstract] [Full Text]
Adams, J. M., Shelton, M. J., Hewitt, R. G., Grasela, T. H., DeRemer, M., Morse, G. D. (1998). Relationship between Didanosine Exposure and Surrogate Marker Response in Human Immunodeficiency Virus-Infected Outpatients. Antimicrob. Agents Chemother. 42: 821-826 [Abstract] [Full Text]
Hogg, R. S., Heath, K. V., Yip, B., Craib, K. J. P., O'Shaughnessy, M. V., Schechter, M. T., Montaner, J. S. G. (1998). Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy. JAMA 279: 450-454 [Abstract] [Full Text]
Thomas, S. A., Segal, M. B. (1997). . J. Pharmacol. Exp. Ther. 281: 1211-1218 [Abstract] [Full Text]
Staszewski, S., Loveday, C., Picazo, J. J., Dellamonica, P., Skinhoj, P., Johnson, M. A., Danner, S. A., Harrigan, P. R., Hill, A. M., Verity, L., McDade, H. (1996). Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Zidovudine-Experienced Patients: A Randomized Controlled Comparison With Zidovudine Monotherapy. JAMA 276: 111-117 [Abstract]
Katlama, C., Ingrand, D., Loveday, C., Clumeck, N., Mallolas, J., Staszewski, S., Johnson, M., Hill, A. M., Pearce, G., McDade, H. (1996). Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Antiretroviral-Naive Patients: A Randomized Controlled Comparison With Zidovudine Monotherapy. JAMA 276: 118-125 [Abstract]
Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., Volberding, P. A. (1996). Antiretroviral Therapy for HIV Infection in 1996: Recommendations of an International Panel. JAMA 276: 146-154 [Abstract]
Moore, R. D., Keruly, J. C., Chaisson, R. E. (1996). Duration of the Survival Benefit of Zidovudine Therapy in HIV Infection. Arch Intern Med 156: 1073-1077 [Abstract]
Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V. J., Friedman, H. M., Merigan, T. C., Reichman, R. C., Hooper, C., Corey, L., The AIDS Clinical Trials Group, (1996). Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine. NEJM 334: 1011-1018 [Abstract] [Full Text]
Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Rooney, J., Meng, T.-C., Fischl, M. A., Collier, A. C., Phair, J. P., Hirsch, M. S., Hardy, W. D., Balfour, H. H., Reichman, R. C., The AIDS Clinical Trials Group, (1995). A Comparison of Immediate with Deferred Zidovudine Therapy for Asymptomatic HIV-Infected Adults with CD4 Cell Counts of 500 or More per Cubic Millimeter. NEJM 333: 401-407 [Abstract] [Full Text]
(1995). Antiretroviral Drug Resistance: Clinical Significance and Implications for HIV Pathogenesis. AIDS Clin Care 1995: 1-1 [Full Text]
Dolin, R., Amato, D. A., Fischl, M. A., Pettinelli, C., Beltangady, M., Liou, S.-h., Brown, M. J., Cross, A. P., Hirsch, M. S., Hardy, W. D., Mildvan, D., Blair, D. C., Powderly, W. G., Para, M. F., Fife, K. H., Steigbigel, R. T., Smaldone, L., AIDS Clinical Trials Group, , National Institute of Allergy and Infectious Disea, , National Institutes of Health, , Bristol-Myers Squibb, , Crumpacker, C. S., Cooley, T., Mitsuyaso, R. T., John, R., Sanders, C., Reitman, D., Hewitt, R., Reichman, R. C., Gelb, L. D., McGuire, M. L., Jones, M., Neidig, J. L., Zwickl, B., Hartman, P. B., Roarke, M. E., Burk, R. A., Fuhrer, J., Somogyi, K. A., Sepkowitz, K., Telzak, E. E., McAuliffe, V. J., Valentine, F. T., Vasquez, M., Merigan, T. C., Katzenstein, D., Fessell, J., Havlir, D. V., Richman, D. D., Spector, S. A., Kahn, J. O., Johnson, L., Coleman, R., Ho, M., McMahon, D., Pazin, G., Antoniskis, D., McNamara, B., Diamond, D., Collier, A. C., Paradise, M. A., Wald, A., DePaolis-Jones, A., Henry, K., Waskin, H. A., Hyslop, N. E. Jr, Mushatt, D. M., Zachary, J. A., Soeiro, R., Harris, C., Zingman, B., Giordano, M. F., Sledz, S., Murray, H. W., Carey, J. T., Davis, T. L., Bagby, B., Kessler, H. A., Murphy, R. I., Hirschtick, R. E., Cheeseman, S. H., Lai, K. K., Fairchild, P. G., Ehmann, W. C., Zurlo, J. J., Millard, R., Troiani, L., Heggen, A. A., van der Horst, C. M., McKinley, G. F., Grieco, M. H., Kolatch, B. R., Goldsmith, J. C., Gomperts, E. D., Woods, L. M., Grue, L., Mayjo, K., Becker, R. L., Jayaweera, D. T., Rolfe, L., Cole, J., Jermano, J. (1995). Zidovudine Compared With Didanosine in Patients With Advanced HIV Type I Infection and Little or No Previous Experience With Zidovudine. Arch Intern Med 155: 961-974 [Abstract]
O'Connor, P. G., Selwyn, P. A., Schottenfeld, R. S. (1994). Medical Care for Injection-Drug Users with Human Immunodeficiency Virus Infection. NEJM 331: 450-459 [Full Text]
Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Balfour, H. H. Jr, Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Phair, J. P., Mitsuyasu, R. T., Fischl, M. A., Soeiro, R., the AIDS Clinical Trials Group of the National Ins, , Pettinelli, C. B., Martinez, A. I., Liou, S.-H., Henry, K., Simpson, M., DePaolis-Jones, A., Hewitt, R. G., Blair, D. C., Packard, M. V., Fowler, C., Crumpacker, C. S., Allan, J. D., Fitch, H. F., Dybeck, K., Coleman, R., Jacobson, M., Phair, J. P., Murphy, R., Benson, C., Hardy, W. D., Chafey, S. A., Kruger, S., Reese, J., Dale, E., Harris, C., Steigbigel, N., Becker, R. L., Rexroad, V. E., Feinberg, J. E., Spector, S. A., Richman, D. D., Snyder, R., Merigan, T. C. Jr, Fessel, J., Katzenstein, D., Zachary, J. A., Mushatt, D. M., Hyslop, N. E. Jr, Collier, A. C., Corey, L., Coombs, R. W., Para, M. F., Fass, R. J., Whitacre, C., Sacks, H. S., Mildvan, D., Mendoza, H., Fife, K., Powderly, W. G., Gelb, L. D., Klebert, M., Leedom, J. M., Liggins, M., Quesada, N., Wong, B., Brinkdopke, J., Hoelle, M., Gocke, D. J., McAuliffe, V. J., Valentine, F. T., Dowling, J., Wallace, M., PaulJarrett, V., Cargill, V., McKinley, G. F., Grieco, M. H., Polsky, B., Brown, D. C., van der Horst, C., Fiscus, S., Ragan, D., Cheeseman, S. H., Fairchild, P. G., Lai, K. K., Ho, M., McMahon, D., Armstrong, J. A., Eyster, M. E., Ehmann, W. C., Irwin, D., Steigbigel, R. T., Fuhrer, J., Tenzler, R., Ponticello, L., Giordano, M. F., Murray, H. W. (1994). The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection: Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group. JAMA 272: 437-442 [Abstract]
Moore, R. D., Stanton, D., Gopalan, R., Chaisson, R. E. (1994). Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community. NEJM 330: 763-768 [Abstract] [Full Text]
Abrams, D. I., Goldman, A. I., Launer, C., Korvick, J. A., Neaton, J. D., Crane, L. R., Grodesky, M., Wakefield, S., Muth, K., Kornegay, S., Cohn, D. L., Harris, A., Luskin-Hawk, R., Markowitz, N., Sampson, J. H., Thompson, M., Deyton, L., The Terry Beirn Community Programs for Clinical Re, (1994). A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection. NEJM 330: 657-662 [Abstract] [Full Text]
Saag, M. S. (1994). What to Do When Zidovudine Fails. NEJM 330: 706-707 [Full Text]
Burack, J. H., Barrett, D. C., Stall, R. D., Chesney, M. A., Ekstrand, M. L., Coates, T. J. (1993). Depressive Symptoms and CD4 Lymphocyte Decline Among HIV-Infected Men. JAMA 270: 2568-2573 [Abstract]
Fox, N. W., McArthur, C. P. (1993). Acquired Immunodeficiency Syndrome-- A Review and Update: History, Characteristics of Human Immunodeficiency Virus Infection, Its Replication, Biologic Factors, and Pathogenicity. Arch Fam Med 2: 1068-1077 [Abstract]
Stoeckle, M. Y., Douglas, R. G. Jr (1993). Infectious Diseases. JAMA 270: 223-224 [Abstract]
Landonio, G., Nosari, A., Spinelli, F., Pechere, M., Samii, K., Hirschel, B., Ballem, P., Belzberg, A., Devine, D. (1993). HIV-Related Thrombocytopenia. NEJM 328: 1785-1786 [Full Text]
Hirsch, M. S., D'Aquila, R. T. (1993). Therapy for Human Immunodeficiency Virus Infection. NEJM 328: 1686-1695 [Full Text]
Johnston, M., Hoth, D. (1993). Present status and future prospects for HIV therapies. Science 260: 1286-1293 [Abstract]
Jewett, J. F., Hecht, F. M. (1993). Preventive Health Care for Adults With HIV Infection. JAMA 269: 1144-1153 [Abstract]

Comments and questions? Please contact us.